N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide

C26H36FN5O3S — CID 176822178

IUPACN-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide
SMILESO=S(=O)(N[C@H]1CCN(c2cccnn2)C[C@H]1OCC1CCC(c2cccc(F)c2)CC1)N1CCCC1
InChIInChI=1S/C26H36FN5O3S/c27-23-6-3-5-22(17-23)21-10-8-20(9-11-21)19-35-25-18-31(26-7-4-13-28-29-26)16-12-24(25)30-36(33,34)32-14-1-2-15-32/h3-7,13,17,20-21,24-25,30H,1-2,8-12,14-16,18-19H2/t20?,21?,24-,25+/m0/s1
InChIKeyUSRHFCIPQZSPQX-JNNLDFGZSA-N
MW517.67 g/mol
LogP3.48
Rot. Bonds8

About N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide

N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide (PubChem CID 176822178) has the molecular formula C26H36FN5O3S and a molecular weight of 517.67 g/mol. Its IUPAC name is N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide.

Molecular Properties

Compound NameN-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide
PubChem CID176822178
Molecular FormulaC26H36FN5O3S
Molecular Weight517.67 g/mol
Exact Mass517.25
IUPAC NameN-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide
SMILESO=S(=O)(N[C@H]1CCN(c2cccnn2)C[C@H]1OCC1CCC(c2cccc(F)c2)CC1)N1CCCC1
InChIInChI=1S/C26H36FN5O3S/c27-23-6-3-5-22(17-23)21-10-8-20(9-11-21)19-35-25-18-31(26-7-4-13-28-29-26)16-12-24(25)30-36(33,34)32-14-1-2-15-32/h3-7,13,17,20-21,24-25,30H,1-2,8-12,14-16,18-19H2/t20?,21?,24-,25+/m0/s1
InChIKeyUSRHFCIPQZSPQX-JNNLDFGZSA-N
XLogP3.48
TPSA87.66 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500517.67
LogP ≤ 53.48
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide?
The IUPAC name of N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide (CID 176822178) is N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide.
What is the SMILES notation for N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide?
The canonical SMILES for N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide is O=S(=O)(N[C@H]1CCN(c2cccnn2)C[C@H]1OCC1CCC(c2cccc(F)c2)CC1)N1CCCC1.
What is the InChIKey of N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide?
The InChIKey is USRHFCIPQZSPQX-JNNLDFGZSA-N. The full InChI is InChI=1S/C26H36FN5O3S/c27-23-6-3-5-22(17-23)21-10-8-20(9-11-21)19-35-25-18-31(26-7-4-13-28-29-26)16-12-24(25)30-36(33,34)32-14-1-2-15-32/h3-7,13,17,20-21,24-25,30H,1-2,8-12,14-16,18-19H2/t20?,21?,24-,25+/m0/s1.
What are the key properties of N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide?
N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide has a molecular weight of 517.67 g/mol, XLogP of 3.48, 8 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,4S)-3-[[4-(3-fluorophenyl)cyclohexyl]methoxy]-1-pyridazin-3-ylpiperidin-4-yl]pyrrolidine-1-sulfonamide is sourced from PubChem (CID 176822178), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).